Since it has been confirmed that IL-6 and IL-6 mRNAs are released by GBM both in vitro and in vivo, IL-6 is considered the key GBM-derived molecule that is often associated with poor prognosis 33, 34. The gene discussed is IL6; the disease is glioblastoma.